Purpose: The present study aimed to determine whether treating symptomatic Conjunctivochalasis (CCh) patients with Atmospheric Low-Temperature Plasma (ALTP) can stimulate inflammatory responses or not; if yes, are they in a stable state and how long do they take back to the normal range? Methods: In this study, 20 patients with definite CCh -with a grade of 3 and 4 -were recruited (identifier: IRCT20181229042160N3). ALTP was generated and used to undertake the surgery; the digital camera examinations were used to follow up the clinical outcomes after surgery. Tear and serum samples were isolated from each patient at 1 week, 1 month, and 3 months after treatment, and the concentration of candidate pro-inflammatory (i.e. IL-2, IL-6, IL-17A, IFN-γ, and TNF-α) and anti-inflammatory cytokines (IL-4 and IL-10) was measured using flow cytometry. Results: In all patients, grades 3 and 4 of CCh were substantially improved to grades 1 and 2, respectively; clinically, after one month, no complications were reported in the eyes that were subjected to ALTP-based surgical procedure. Besides, the analyses revealed that the ALTP-based treatment could improve the 'Ocular Surface Disease Index' score. Interestingly, regarding the concentration of the candidate cytokines in the tear and serum samples, no differences were observed at pre- and post-surgery follow-ups. Conclusion: In sum, we reintroduced using the Plasma-Assisted Noninvasive Surgery method as a novel approach to treat CCh because of its accurate handy nature with no stimulated inflammatory responses.
No takes yet. Share an insight, caveat, or question.
Nejat et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: